Stockhead says healthcare shares sold off this week while TTX may benefit from looser US peptide rules.
Why it mattersRule changes in one market can quickly change valuations for listed health names. That matters for anyone holding small biotech stocks.
Free. Start reading in seconds, no signup needed.
Get the free app, read the whole feed
InSnip is the day's best stories, source-backed and read in under a minute. Get your free daily drop and never miss what matters.